Skip to main content
  • Research article
  • Open access
  • Published:

Neonatal assessment in the delivery room – Trial to Evaluate a Specified Type of Apgar (TEST-Apgar)



Since an objective description is essential to determine infant’s postnatal condition and efficacy of interventions, two scores were suggested in the past but weren’t tested yet: The Specified-Apgar uses the 5 items of the conventional Apgar score; however describes the condition regardless of gestational age (GA) or resuscitative interventions. The Expanded-Apgar measures interventions needed to achieve this condition. We hypothesized that the combination of both (Combined-Apgar) describes postnatal condition of preterm infants better than either of the scores alone.


Scores were assessed in preterm infants below 32 completed weeks of gestation. Data were prospectively collected in 20 NICU in 12 countries. Prediction of poor outcome (death, severe/moderate BPD, IVH, CPL and ROP) was used as a surrogate parameter to compare the scores. To compare predictive value the AUC for the ROC was calculated.


Of 2150 eligible newborns, data on 1855 infants with a mean GA of 286/7 ± 23/7 weeks were analyzed. At 1 minute, the Combined-Apgar was significantly better in predicting poor outcome than the Specified- or Expanded-Apgar alone. Of infants with a very low score at 5 or 10 minutes 81% or 100% had a poor outcome, respectively. In these infants the relative risk (RR) for perinatal mortality was 24.93 (13.16-47.20) and 31.34 (15.91-61.71), respectively.


The Combined-Apgar allows a more appropriate description of infant’s condition under conditions of modern neonatal care. It should be used as a tool for better comparison of group of infants and postnatal interventions.

Trial registration Protocol Registration System (NCT00623038). Registered 14 February 2008.

Peer Review reports


An objective assessment of infant’s postnatal condition in the delivery room is essential for clinical care and scientific purposes. To describe the postnatal condition of groups of infants or to compare effects of interventions in a research setting a numerical score, which represents the sum of several objective findings is required.

To describe the condition of a newborn, Virginia Apgar developed a system that scores the postnatal condition by converting clinical observations into quantifiable scientific data [1]. However, there is no general agreement on how to score infants with a low gestational age or those receiving interventions [2-4]. To overcome that problem, we suggested to specify the items of the conventional Apgar and to score infant’s condition regardless of gestational age and interventions (Specified-Apgar) [5]. According to the rules of the Specified-Apgar, the full score with a maximum total of 10 points can either be allocated to the healthy term or preterm infant without any problems in postnatal adaptation, but also to an infant receiving resuscitative or supportive interventions with an adequate response to those interventions (good chest expansion during ventilation, pink skin colour due to supplemental oxygen, etc.). To better differentiate between both conditions, the American Academy of Pediatrics (AAP) and American College of Obstetricians and Gynecologists (ACOG) suggested to also score and document the interventions that are required to achieve the condition (Expanded-Apgar) [6]. Consequently, an infant without any interventions would have a higher Expanded-Apgar than the one who requires interventions. It can be assumed that an infant’s condition is better described using both scores (Combined-Apgar) simultaneously than one score alone.

Up until now, both scores are not used in clinical practise mainly because of not being validated yet.

The multicenter, international TEST-Apgar study (“Trial to Evaluate a Specified Type of Apgar”) aimed to answer the question, whether the Combined-Apgar describes infant’s postnatal condition better than either the Specified-Apgar or Expanded-Apgar alone. Since no “gold standard” was available, we decided to use prediction of mortality and morbidity as a proxy for testing. That outcome criterion was only used as a surrogate parameter for the purpose of testing the scores. It was not the aim to develop a new tool which predicts mortality or morbidity, but to test that the Combined-Apgar provides a good numerical description of infant’s postnatal condition.

Therefore, the primary hypothesis of the TEST-Apgar study was as follows: the Combined-Apgar is a better predictor of poor outcome in preterm infants (defined as either death or any major morbidity during the first hospital stay) than either the Specified-Apgar or Expanded-Apgar alone.


In an observational study data were collected prospectively in 20 academic neonatal intensive care units (NICU) in 12 countries from March 2008 to June 2009.

Inclusion and exclusion criteria

Infants were eligible if they were born at any of the study sites prior to 32 completed weeks of gestation. The exclusion criteria were: 1.) lack of informed consent, 2.) outborn, 3.) any major congenital malformation, or 4.) death in the delivery room.


After birth, the following data were collected by the attending neonatologist: gestational age, birth weight, mode of delivery and a description of the infant at 1, 5 and 10 minutes of life according to the definition of the Combined-Apgar, which consists of the Expanded-Apgar and Specified-Apgar as shown in Table 1:

Table 1 Combined-Apgar consisting of the Expanded-Apgar and Specified-Apgar
  1. 1.

    Specified-Apgar [5]: Muscle tone and reflex response were evaluated in relation to GA as being appropriate (2 points), reduced (1 point) or absent (0 points). Chest movement was evaluated regardless of the respiratory support given and was scored 2 if chest movements were appropriate, with 1 point if chest movements were reduced, irregular or signs of respiratory distress were present, and scored 0 if no chest movement was present. Skin color and heart frequency were evaluated as detailed in Table 1, regardless of the intervention needed to achieve this condition.

  2. 2.

    Expanded-Apgar [6]: Presence or absence of the following interventions was evaluated: continuous positive airway pressure (CPAP), oxygen supplementation, bag and mask ventilation, intubation and ventilation, chest compression, administration of surfactant, epinephrine (drugs). If an intervention was performed it was scored 0, if absent it was scored 1. The best possible score was 7 (no intervention) and the worst 0 (all interventions performed). Intubated and ventilated infants were scored 0 for CPAP as well as for bag and mask ventilation; infants on bag and mask ventilation were scored 0 for CPAP as well.

  3. 3.

    Combined-Apgar: In clinical routine, the Combined-Apgar will consist of two numbers, such as 7–10 for the Expanded- and Specified-Apgar, respectively (Table 1). For the purpose of the present study, the Combined-Apgar was calculated as the sum of the Specified- and the Expanded-Apgar.

At discharge the following outcome measures were recorded: mode of discharge (death, transfer to another hospital, or home), length of stay, corrected GA, weight, and the presence of either of the four major morbidities: moderate/severe bronchopulmonary dysplasia (BPD) [7], intraventricular haemorrhage grade 1–4 (IVH), cystic periventricular leukomalacia (CPL), and retinopathy of prematurity (ROP).

Data management and statistical analyses

Participating doctors were instructed regarding definitions and study forms prior to the start of the study at the individual center. Data collected at participating sites were transmitted to the principal investigator and analyzed for the primary outcome criterion consisting of death or either one of the major morbidities (BPD, IVH, CPL, ROP). To test the hypothesis, the predictive values of the scores were compared by calculating the areas under the curve (AUC) and their co-variances of the receiver-operating-characteristics (ROC), based on an algorithm given by DeLong and co-workers [8]. The comparisons of AUCs base on WALD tests. The significance of differences between estimated risks was tested by Chi-square tests; p-values are unadjusted for multiple testing. For sample size calculation a difference in AUC means of 0.01 and a SD in matched pairs of 0.1 were assumed. To detect a significant difference at a level of p = 0.01 with a power of 0.9 data of 1490 infants were required. Assuming a dropout rate of 30%, it was planned to recruit 2000 patients. For secondary data analysis, the AUC was calculated for each individual component of poor outcome. Data on mortality were analyzed for “death at any point” and “perinatal mortality”. Furthermore, for each outcome criteria the relative risk (RR) and 95% confidence interval (95%-CI) were calculated. To do so, scores were categorized as follows: Specified-Apgar: poor (0–3 points), fair (4–6 points) or good (7–10 points) [9], Expanded-Apgar: low (0–2 points), moderate (3–4 points), high (5–6 points) or no intervention (7 points); Combined-Apgar: very low (0–5 points), low (6–9 points), moderate (10–13 points) or high (14–17 points). The respectively highest category of each score was used as reference value. All analyses were performed by using SAS (SAS Institute Inc., Cary, NC, version 9.2).

Ethics committee approval

Approval was given by the Ethics Committee of the Medical Faculty Carl Gustav Carus, Dresden, Germany (EK 104052008) and in all participating centers. Written informed consent was obtained from the infant’s parents before taking part in the study. The study was registered on Protocol Registration System (NCT 00623038).


Patient characteristics

In total, 2150 infants were eligible for the study. Two hundred ninety five had to be excluded from analysis for the following predetermined reasons: Missing parental consent (n = 28), outborn (n = 24), congenital anomalies (n = 16), palliative care (n = 16), transferral within first week of life (n = 3), no paediatrician present (n = 2), incomplete data (n = 143), other reasons (n = 63). Perinatal data of excluded patients (mean GA of 283/7 ± 23/7 weeks, birth weight 1119 ± 388 g) were statistically not different from those of analyzed patients.

Data of 1855 patients were analyzed, representing in median 89 (Range 21–228) patients per center with a mean GA of 286/7 ± 23/7 weeks and birth weight of 1172 ± 409 g.

The overall mortality rate was 10.6%. For the individual centers, the median mortality rate was 8.8% [Interquartile Range (IQR) 4.8-12.3%]. Infants were discharged home at a median postconceptional age of 362/7 weeks (length of stay in survivors 53 [IQR 35–75] days).

Gestational age – effect on clinical condition and need for medical interventions

The postnatal condition during the first minute of life showed a linear correlation with gestational age; with the Specified-Apgar scoring higher at higher gestational age (Figure 1A). In contrast, there was no linear correlation between gestational age and medical interventions (Expanded-Apgar) at one minute; medical support was almost similar for infants below 28 weeks of gestation (Figure 1C).

Figure 1
figure 1

Distribution-pattern of the Specified-Apgar (A, B) and Expanded-Apgar (C, D) at 1 and 10 minutes. In the boxplot, the central box represents the values from the lower to upper quartile (25 to 75 percentile). The middle line represents the median. The vertical line extends from the minimum to the maximum value. Outlier values are displayed as black dots, extreme values are displayed as an asterix.

At 10 minutes, clinical condition of all infants was similar regardless of gestational age (Figure 1B). However, medical support to achieve this condition increased with decreasing gestational age (Figure 1D).

Primary outcome measure – prediction of poor outcome

To test the primary hypothesis, the AUC of ROC-curves for prediction of poor outcome were calculated and compared (Table 2). At 1 minute, the Combined-Apgar predicts poor outcome significantly better than the Specified- or Expanded-Apgar alone. At 5 and 10 minutes, the Combined-Apgar predicts poor outcome better than the Specified-Apgar. However, there were no significant differences in predicting poor outcome between Combined- and Expanded-Apgar at 5 and 10 minutes.

Table 2 Area under the curve (AUC) of the ROC-Curve for the Specified-Apgar , Expanded-Apgar and Combined-Apgar

Analysis of the single components of outcome revealed that overall morbidity in survivors was better predicted by the number of interventions (Expanded-Apgar) at 5 and 10 minutes than by the actual condition (Specified-Apgar) of the infant at that time (see Additional file 1: Table A and Additional file 2: Table E). In contrast, death (especially perinatal mortality) was better predicted by the postnatal condition (Specified-Apgar) (see Additional file 2: Table F). The Combined-Apgar was significantly better to predict perinatal mortality than the Specified- or Expanded-Apgar alone (see Additional file 3: Table J; Additional file 2: Table F and Additional file 1: Table B).

Relative risk for morbidity or mortality for each score

Detailed data on the relative risk for morbidity and mortality can be found as additional files (for the Expanded-Apgar see Additional file 1: Table A-D; for the Specified-Apgar see Additional file 2: Tables E-H; and for the Combined-Apgar see Additional file 3: Tables I-L).

Infants with a persistently poor Specified-Apgar (<4) up to minute 5 or minute 10 had a poor outcome in 75% or 93% (RR 1.67 [95%-CI 1.41 to 1.98] or 2.08 [1.80 to 2.40]), respectively. If the five outcome parameters were analyzed separately, the Specified-Apgar cannot be used to predict the morbidity risk. Best prediction was found for mortality: the risk of death was significantly increased with a poor and a fair Specified-Apgar (see Additional file 2: Table F).

In 30% or 24% the Expanded-Apgar remained below 5 for up to 5 or 10 minutes, respectively. Less than 1% had an Expanded-Apgar below 3 for up to 5 or 10 minutes. The risk of poor outcome was below 30% in infants without any intervention; however, it increased to above 50% with a moderate (score 3–4) and above 60% with a low (score 0–2) Expanded-Apgar (see Additional file 1: Table A). For the Combined-Apgar, the relative risk of poor outcome increased with a decreasing score (see Additional file 3: Table I). As shown in Figure 2, a very low Combined-Apgar was associated with an about 30-fold increased risk for perinatal mortality.

Figure 2
figure 2

Combined-Apgar : Relative risk for perinatal mortality.


A numerical score that represents the sum of objective findings is a prerequisite to describe the postnatal condition or to compare effects of interventions in the delivery room for groups of infants. Since the infant’s condition is affected by medical interventions, it seems mandatory to describe not only the clinical status but also the interventions needed to achieve this condition. During the last centuries, various attempts have been made to describe the infant’s condition after birth [10-12]. Virginia Apgar developed a scoring system that now bears her name and is widely used [1]. Since improvements in neonatal care demanded a recalibration of the Apgar score [13], the Specified-Apgar was introduced. Using the same items as the original score, it allows detailed descriptions for the infant’s condition regardless of GA or interventions [5]. To account for medical interventions required to achieve this condition the AAP and ACOG suggested an expanded reporting form for concurrent resuscitative interventions (Expanded-Apgar) [6]. Both scores together give an objective measure of the postnatal condition; however this Combined-Apgar has not been used in clinical studies yet. The multicenter international TEST-Apgar study tested both scores for the first time in a clinical setting. The data show that the combination of assessing infant’s condition and administered interventions (Combined-Apgar) is better (to predict death) than the description of condition or interventions alone.

The description of the postnatal condition is incomplete without considering administered interventions. The Expanded-Apgar adds seven items as a measure for medical interventions needed to achieve the infant’s condition [6]. This extension seems long needed, because care of the newborn has changed significantly and an infant’s condition often depends on medical interventions used to support postnatal transition. In the present study, the majority of infants showed a good clinical condition at 10 minutes of life, however, the number of interventions needed to achieve that condition increased with decreasing gestational age.

The seven items of the Expanded-Apgar represent medical interventions that are clearly defined. To our knowledge, this is the first prospective clinical study to show a direct relationship between the number of interventions administered postnatally and subsequent survival. The more interventions were given the more likely the infant died within the first postnatal week. All infants with a Combined-Apgar below 6 for at least 10 minutes had a bad outcome. However, at this moment it remains unclear whether all interventions were clinically indicated or rather done as a result of current practice in individual institutions. More detailed analyses will have to analyze if there are differences in the predictive power of individual items of the Combined-Apgar.

Clinical implications

In the past, the 1-minute Apgar score was used to guide further treatment and the 5-minute score was a useful index of the effect(iveness) of resuscitation efforts [14]. However, it remained unclear how infants were scored during resuscitation. It was suggested to interrupt resuscitation for evaluation purposes [3,15] but this approach seems not practical. The Specified-Apgar describes the condition without interrupting intervention and the Expanded-Apgar adds the required information concerning the interventions. Thus, the Combined-Apgar evaluates both, infant’s condition and resuscitative efforts and can be used to guide postnatal interventions.

A Combined-Apgar of 7–10 represents an infant without any clinical interventions (Expanded-Apgar of 7) and good clinical signs (Specified-Apgar of 10). In contrast a Combined-Apgar of 0–10 represents an infant with full resuscitative interventions (Expanded-Apgar 0) and a good clinical response (Specified-Apgar of 10). Finally, a Combined-Apgar of 0–0 represents an infant with full resuscitative interventions but no clinical response.

Limitations of the study

It has been previously shown that not all items of the conventional Apgar score are of equal importance [9,16]. However, Virginia Apgar did not differentially weigh or remove individual items since it was her intention to have a score that can be “determined easily and without interfering with the care of the infant” [1]. The Combined-Apgar never intended to replace but rather to specify the score that has been used worldwide for almost 60 years. Therefore, items were neither changed nor omitted. Furthermore, definition of skin color was not changed despite its poor correlation with oxygen saturation [17].

Questions that were not answered by the present study

Since there is no other objective measure to describe postnatal condition, poor outcome was used as a surrogate parameter to test the value of the scores in preterm infants. It has already been noted by Virginia Apgar that her score cannot be used to predict survival in an individual infant, but only for a group of infants [18,19]. For a better prediction of outcome in individual infants other more reliable scores should be used [19-21]. But it remains unclear, whether this higher predictive value in individuals is of relevance in clinical routine.

Whereas virtually every newborn is evaluated by the Apgar score today, recent studies suggest problems concerning its reproducibility in individual infants [2-4]. A study, comparing conventional Apgar scores assigned by observers of resuscitation videos to those given by the staff attending the delivery, revealed a poor inter-observer reliability [4]. Similarly, a poor reliability was found when Apgar scores were assessed for written case descriptions [3]. In clinics where case descriptions were scored low, preterm infants received lower Apgar scores as well [2]. It was speculated, that this variability “could also be due to variations in the application of the scoring system” [22]. To overcome its poor reproducibility, the Specified-Apgar was introduced, which gives more detailed descriptions of the infant’s condition regardless of GA or interventions needed to achieve this condition [5]. Strict definitions – as given by the Specified-Apgar – are needed to minimise variability in the description of infant’s condition. However, subsequent studies have to test, whether reproducibility is actually improved by using the Specified-Apgar.

Another important practical aspect of the Combined-Apgar is its applicability for every newborn. The present study has only tested the predictive power in very preterm infants, but the Apgar score is also of importance in resuscitated infants (e.g. it is used as an inclusion criterion for hypothermia) [23]. Considering the large variation in the conventional Apgar score for an individual infant depending on the care givers opinion [2-4], it could be assumed that the Combined-Apgar will be a better discriminator. However, the predictive power of the Combined-Apgar for subsequent neurological impairment has to be tested in asphyxiated infants.


In summary, the present study tested a numerical score (Combined-Apgar) that sums up objective findings upon the condition of the infant in the delivery room and the interventions needed to achieve this condition in a large population of preterm infants. The Combined-Apgar is a good tool to describe the postnatal condition in the delivery room as shown by its ability to predict perinatal mortality for groups of infants. It should be used in subsequent studies that require a detailed description of infant’s postnatal situation.

Availability of supporting data

Additional files (Additional files 1, 2 and 3: Tables A-L) are available as supporting data for the Expanded-, Specified- and Combined-Apgar and the relative risk of poor outcome and morbidity in survivors, death and perinatal mortality, BPD and ROP as well as IVH and CPL.



Area under the curve


Bronchopulmonary dysplasia


Cystic periventricular leukomalacia


Delivery room


Gestational age


Intraventricular haemorrhage


Neonatal intensive care unit




Retinopathy of prematurity


  1. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anaesth Anal. 1953;32:260–7.

    CAS  Google Scholar 

  2. Rüdiger M, Küster H, Herting E, Berger A, Müller C, Urlesberger B, et al. Variations of Apgar Score of very low birth weight infants in different neonatal intensive care units. Acta Paediatr. 2009;98(8):1433–6.

    Article  PubMed  Google Scholar 

  3. Lopriore E, von Burk F, Walther FJ, de Beaufort AJ. Correct use of the Apgar score for resuscitated and intubated newborn babies: questionnaire study. Br Med J. 2004;329(143):144.

    Google Scholar 

  4. O’Donnell CPF, Kamlin COF, Davis PG, Carlin JB, Morley CJ. Interobserver variability of the 5 minute apgar score. J Pediatr. 2006;149:486–9.

    Article  PubMed  Google Scholar 

  5. Rüdiger M, Wauer RR, Schmidt K, Küster H. The Apgar Score [Letter to the Editor]. Pediatrics. 2006;118(3):1314–5.

    Article  PubMed  Google Scholar 

  6. American Academy of Pediatrics. Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists, Committee on Obstetric Practice: The Apgar Score. Pediatrics. 2006;117:1444–7.

    Article  Google Scholar 

  7. Jobe A, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.

    Article  CAS  PubMed  Google Scholar 

  8. DeLong R, DeLong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristics curves: A nonparametric approach. Biometrics. 1988;44:837–45.

    Article  CAS  PubMed  Google Scholar 

  9. Apgar V, James LS. Further observations on the newborn scoring system. Am J Dis Child. 1962;104:419–28.

    CAS  PubMed  Google Scholar 

  10. Dunn PM. Soranus of Ephesus (circa AD 98–138) and perinatal care in Roman times. Arch Dis Child Fetal Neonatal Ed. 1995;73(1):F51–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Runge M. Die Krankheiten der ersten Lebenstage. zweite, umgearbeitete und vermehrte Auflage. 1893. Suttgart, Verlag von Ferdinand Enke.

  12. Soranus E. Gynecology. Translated by O. Temkin. Baltimore: The John Hopkins Press; 1956.

    Google Scholar 

  13. Bharti B, Bharti S. A review of the Apgar score indicated that contextualization was required within the contemporary perinatal and neonatal care framework in different settings. J Clin Epidemiol. 2005;58:121–9.

    Article  PubMed  Google Scholar 

  14. American Academy of Pediatrics. Use and abuse of the Apgar Score. Pediatrics. 1986;78(6):1148–9.

    Google Scholar 

  15. Pinheiro JMB. The Apgar cycle: a new view of a familiar scoring system. Arch Dis Child Fetal Neonatal Ed. 2009;94:F70–2.

    Article  CAS  PubMed  Google Scholar 

  16. Crawford JS, Davies P, Pearson JF. Significance of the individual components of the Apgar score. Br J Anaesth. 1973;45:148–58.

    Article  CAS  PubMed  Google Scholar 

  17. O’Donnell CPF, Kamlin COF, Davis PG, Carlin JB, Morley CJ. Clinical assessment of infant colour at delivery. Arch Dis Child Fetal Neonatal Ed. 2007;92:465–7.

    Article  Google Scholar 

  18. Casey BM, McIntire DD, Leveno KJ. The continuing value of the apgar score for the assessment of newborn infants. N Engl J Med. 2001;344(7):467–71.

    Article  CAS  PubMed  Google Scholar 

  19. Schmidt B, Kirpalani H, Rosenbaum P, Cadman D. Strength and limitations of the Apgar score: A critical appraisal. J Clin Epidemiol. 1988;41(9):843–50.

    Article  CAS  PubMed  Google Scholar 

  20. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340:1234–8.

    Article  CAS  PubMed  Google Scholar 

  21. Saria S, Rajani AK, Gould J, Koller D, Penn AA. Integration of early physiological responses predicts later illness severity in preterm infants. Sci Transl Med. 2010;2(48):48ra65.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Apgar V. The newborn (apgar) scoring system. Pediatr Clin North Am. 1966;13(3):645–50.

    Article  CAS  PubMed  Google Scholar 

  23. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–70.

    Article  PubMed  Google Scholar 

Download references


We would like to thank all parents who gave their consent for their infant to participate in our study. Furthermore we would like to thank the following individuals for their contributions:

Dr. Mohamed Sadik and Dr. Adel El-Sharkawy from Neonatal Intensive Care Unit, Department of Pediatrics, Latifa Hospital, Dubai Health Authority, Government of Dubai, United Arab Emirates; Dr. Klaudia Demova, Dr. Gabriela Magyarova and Prof. Dr. Frantisek Bauer from the Department of Neonatology, Nové Zámky, Slovakia as well as Prof. Dr. Barbara Lubec, from the Medical University Vienna, Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics for supporting the TEST-Apgar study group by collecting data for us in their affiliation. Furthermore we would like to acknowledge Prof. Dr. Rainer Koch for the statistical analysis of our data. Neither of the above mentioned received any compensation for their contributions.

We acknowledge support by the Else Kröner-Fresenius-stiftung, the German Research Foundation (DFG) and the Open Access Publication Funds of the TU Dresden.

Author information

Authors and Affiliations



Corresponding author

Correspondence to Mario Rüdiger.

Additional information

Competing interests

All authors have completed the ICMJE uniform disclosure form at (available on request from the corresponding author) and declare: Only Mario Rüdiger and Nicole Braun received a research grant for the submitted work from the Else Kröner-Fresenius-Stiftung. Despite that, there are no financial relationships with any organisations that might have an interest in the submitted work in the previous 5 years; no other relationships or activities that could appear to have influenced the submitted work. The authors declare that they have no competing interests.

Authors’ contributions

MR, NB, HK and JA were part of the steering committee of the TEST-Apgar Trial. They were responsible for the conception of the study, analysis of data and the drafting of the initial manuscript. All authors of the TEST-Apgar study group (MR, NB, JA, MA, RB, AB, GD, KE-A, SI, PJ, KM, VO, ZP, CR, JS, BS, NS, GV, MGV, MV*, MV, BW, AW, SY, HZ, HK) acquired the data, improved the design of the study, discussed the interpretation of the data, critically revised the final manuscript for important intellectual content and subsequently approved the final version to be published. They agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Furthermore MR, NB; HK and JA were responsible for the statistical analysis. All authors read and approved the final manuscript.

Additional files

Additional file 1:

Expanded-Apgar and the relative risk of… (Table A): … poor outcome and morbidity in survivors (page 23), (Table B): … death and perinatal mortality (page 24), (Table C): … BPD and ROP (page 25), (Table D): … IVH and CPL (page 26).

Additional file 2:

Specified-Apgar and the relative risk of… (Table E): … poor outcome and morbidity in survivors (page 27), (Table F): … death and perinatal mortality (page 28), (Table G): … BPD and ROP (page 29), (Table H): … IVH and CPL (page 30).

Additional file 3:

Combined-Apgar and the relative risk of… (Table I): … poor outcome and morbidity in survivors (page 31), (Table J): … death and perinatal mortality (page 32), (Table K): … BPD and ROP (page 33), (Table L): … IVH and CPL (page 34).

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rüdiger, M., Braun, N., Aranda, J. et al. Neonatal assessment in the delivery room – Trial to Evaluate a Specified Type of Apgar (TEST-Apgar). BMC Pediatr 15, 18 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: